Key result
New community EP program achieves a ~0.4% rate of early major device complications.
Why the study?
What are the early (<6 weeks) complication rates, hospital utilization, and left ventricular lead placement success rates of cardiac device implantations in a non-academic community hospital electrophysiology program?
Cohort (n=250)
No
What are the early (<6 weeks) complication rates, hospital utilization, and left ventricular lead placement success rates of cardiac device implantations in a non-academic community hospital electrophysiology program?
Demonstrates that a newly established non-academic community hospital electrophysiology program can treat an elderly, comorbid population with low early complication rates (0.4% major, 2.8% minor) and high LV lead placement success (97%).
Answers are grounded in this paper and cite their sources.
May support safe device implantation in new community EP programs; leaves open generalizability beyond single-operator experience.
BACKGROUND: Single-center reports on patient demographics and early (<6 weeks) device complication rates in academic hospitals are scant and non-existent for non-academic community hospital electrophysiology (EP) programs. OBJECTIVE: The objective of our study was to examine the demographics, complications, re-admissions, and accessibility of care in a community EP program to add to the body of knowledge of 'real-world' defibrillator implant complications. METHODS: Two hundred and fifty consecutive patients who underwent device implantation by a single electrophysiologist in a new non-academic community hospital EP program starting from its inception in July 2008 were included for analysis. Standard procedures for implantation were used. Pacemakers, defibrillators, and generator changes were included; temporary pacemakers were excluded. Major complications were defined as in-hospital death, cardiac arrest, cardiac perforation, cardiac valve injury, coronary venous dissection, hemothorax, pneumothorax, transient ischemic attack, stroke, myocardial infarction, pericardial tamponade, and arteriovenous fistula. Minor complications were defined as drug reaction, conduction block, hematoma or lead dislodgement requiring re-operation, peripheral embolus, phlebitis, peripheral nerve injury, and device-related infection. RESULTS: This community cohort had similar ejection fractions but was older with worse kidney function than those studied in prior reports. There was one major early complication (0.4%) and seven minor early complications (2.8%). Left ventricular lead placement was successful in 64 of 66 patients (97%). CONCLUSIONS: This is the first community-hospital-based EP program to examine device implant demographics and outcomes, and revealed an elderly, ill population with lower overall rates of complications than seen in national trials and available reports from single non-community centers. Contrary to current perceptions, these data suggest that community centers may subselect an elderly, ill patient population and can provide high-quality, cost-effective, and more accessible care.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2010) conducted a cohort in Cardiac arrhythmia and heart failure requiring cardiac implantable electronic device implantation (n=250). Cardiac implantable electronic device implantation (pacemaker, ICD, bi-ventricular ICD, or generator change) in a community hospital EP program was evaluated on Early (<6 weeks) major device-related complications (in-hospital death, cardiac arrest, cardiac perforation, cardiac valve injury, coronary venous dissection, hemothorax, pneumothorax, TIA, stroke, MI, pericardial tamponade, arteriovenous fistula). Cardiac device implantation in a new community hospital EP program resulted in a 0.4% major complication rate, 2.8% minor complication rate, and 97% LV lead success rate over 6 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: